Novel Vaccine Against Trypanosoma Cruzi Infection
The present invention relates to a vaccine against Trypanosoma cruzi infection, useful in the prevention and/or treatment of the Chagas disease. More specifically, the present invention relates to a recombinant mutant trans-sialidase enzyme that can be used as an efficient vaccine, without side effects.
Patents:US 20,110,038,887
Inventor(s):
CONTRERAS ROLAND [BE]; DE VUSSER KRISTOF [BE]; REVELLI SILVIA [AR]
Type of Offer:
Sale
« More Pharmaceutical Patents